Balance Sheet
Cash Flow Statement
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

CV Sciences (CVSI) Operating Expenses (2016 - 2025)

Historic Operating Expenses for CV Sciences (CVSI) over the last 14 years, with Q3 2025 value amounting to $1.9 million.

  • CV Sciences' Operating Expenses fell 1250.59% to $1.9 million in Q3 2025 from the same period last year, while for Sep 2025 it was $8.3 million, marking a year-over-year decrease of 1434.89%. This contributed to the annual value of $9.4 million for FY2024, which is 590.25% down from last year.
  • As of Q3 2025, CV Sciences' Operating Expenses stood at $1.9 million, which was down 1250.59% from $2.0 million recorded in Q2 2025.
  • CV Sciences' Operating Expenses' 5-year high stood at $10.5 million during Q4 2021, with a 5-year trough of $1.9 million in Q3 2025.
  • In the last 5 years, CV Sciences' Operating Expenses had a median value of $2.5 million in 2024 and averaged $3.4 million.
  • Per our database at Business Quant, CV Sciences' Operating Expenses crashed by 6472.78% in 2022 and then skyrocketed by 1287.08% in 2024.
  • CV Sciences' Operating Expenses (Quarter) stood at $10.5 million in 2021, then crashed by 64.73% to $3.7 million in 2022, then fell by 27.31% to $2.7 million in 2023, then dropped by 13.32% to $2.3 million in 2024, then fell by 20.19% to $1.9 million in 2025.
  • Its last three reported values are $1.9 million in Q3 2025, $2.0 million for Q2 2025, and $2.2 million during Q1 2025.